Hyaluronidase Treatment
Hyaluronidase Treatment - Related Videos
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
0 Views •
Cited by 26 •
2013
Psoriasis is a chronic, immune-mediated inflammatory skin disease. The Goeckerman regimen, formulated for the treatment of psoriasis, consists of exposure to ultraviolet B (UVB) light and application of crude coal tar (CCT). The following protocol is for the administration of Goeckerman therapy for the treatment of moderate-to-severe psoriasis.
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
0 Views •
Cited by 31 •
2015
Here we outline the procedure for MRI-guided repetitive transcranial magnetic stimulation to the dorsomedial prefrontal cortex as an experimental treatment for major depressive disorder.
08:01
Rockwell Hardness Test and the Effect of Treatment on Steel
0 Views •
2023
Source: Roberto Leon, Department of Civil and Environmental Engineering, Virginia Tech, Blacksburg, VA Hardness testing is one of the most universally valuable mechanical tests available to engineers, as it is both simple and relatively inexpensive for the wealth of information and data it produces. Hardness testing, generally in the form of a surface penetration test, is both quicker and less destructive than tensile testing. Hardness provides a linear relationship with tensile strength over a...
08:34
The Measurement and Treatment of Suppression in Amblyopia
0 Views •
Cited by 54 •
2012
Amblyopia is a developmental disorder of the visual cortex that is often accompanied by strong suppression of one eye. We present a new technique for measuring and treating interocular suppression in patients with amblyopia that can be deployed using virtual reality goggles or a portable iPod Touch device.
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
0 Views •
Cited by 19 •
2011
A thermal tumor ablation procedure is described. The entire procedure is detailed, including pretreatment planning and imaging studies, anesthesia, adjuvant techniques to facilitate a percutaneous approach, imaging guidance of the ablation device to the tumor, thermal treatment, post-treatment care and follow-up.
FAQs
Hyaluronidase hydrolyzes hyaluronic acid polymers within connective tissue. This reduces the viscosity of the matrix temporarily, making it less resistant to movement through the affected region. As a result, fluids and injected substances can spread more readily. The key biological effect is therefore a temporary change in extracellular matrix structure and transport properties rather than permanent tissue remodeling.
The response depends on how much enzyme reaches the tissue, where the enzyme is applied, and which material is present. These variables influence the extent of hyaluronic acid breakdown and the resulting change in tissue permeability. Consequently, the same treatment can produce different degrees of fluid movement, drug dispersion, or filler degradation in different biological settings.
For transport, the enzyme temporarily reduces connective-tissue viscosity so fluids or selected drugs can disperse and absorb more readily. With a hyaluronic acid-based dermal filler, the relevant outcome is breakdown of the filler material itself. Both uses depend on enzymatic hydrolysis, but they apply the resulting change to different practical goals: improving movement through tissue or reducing an implanted material.
Because it selectively changes hyaluronic acid polymers, hyaluronidase treatment provides a way to examine how extracellular matrix composition affects tissue permeability and transport. Observing changes after treatment can help connect matrix breakdown with the movement of fluids or injected substances. This makes the enzyme useful for studying biological transport in addition to its applied medical uses.
It is used when reducing the viscosity of connective tissue can help subcutaneously administered fluid spread through the affected area. By increasing tissue permeability temporarily, the enzyme supports movement of the fluid beyond the immediate injection site. The usefulness of this application still depends on treatment dose and tissue location, which influence how broadly the fluid can disperse.
Hyaluronidase can improve the dispersion and absorption of selected drugs by hydrolyzing hyaluronic acid in connective tissue. The resulting temporary reduction in matrix viscosity allows an injected substance to move more readily through the area. This effect is material-dependent, so the technique is relevant to selected drugs rather than serving as a universal enhancement for every injected medication.